Cardinal Health issued rosy profit guidance and some analyst lifted a price target. The quarter wasn't totally clean. Strong profitability matters the most. These are three separate thoughts masquerading as a coherent investment thesis.
Profitability matters the most. Not revenue growth. Not market share. Not competitive moat. Not management competence. Just profitability. The same metric every company on Earth tries to generate and the one thing Cardinal Health apparently forgot to do consistently enough that when they remember how it's considered rosy guidance worth a price target bump.
The quarter wasn't totally clean. What a spectacular way to describe financial results. Not good. Not bad. Not mixed. Not challenging. Wasn't totally clean. Like finding a hair in your soup but eating it anyway because you're hungry and already paid.
Some retail trader is reading this headline right now and thinking he cracked the code. Cardinal Health prints money when they feel like it. Guidance goes up. Stock goes up. He'll buy calls at open and watch the implied volatility crush him like a grape while the stock trades sideways for six weeks because the smart money already priced this in before Cardinal Health's CFO finished typing the press release.
The analyst who lifted the price target will appear on CNBC. He'll say the word execution fourteen times. He'll mention tailwinds. He'll talk about operational efficiency gains in pharmaceutical distribution like he's describing a moon landing. The host will nod. Nobody will ask what the price target was before or why it matters now.
Cardinal Health will continue existing as a company that sometimes makes more profit than expected and sometimes makes less, and analysts will continue moving price targets up and down like they're adjusting a thermostat in a house that's already on fire.
Photo by on Unsplash
Leave a Comment